{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T13:31:51Z","timestamp":1791639111512,"version":"4.3.4"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T00:00:00Z","timestamp":1754870400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chongqing Joint Medical Scientific Research Program","award":["2021MSXM224"],"award-info":[{"award-number":["2021MSXM224"]}]},{"name":"Innovation Team Project of Bishan Hospital of Chongqing","award":["No. BYKY-CX2023019"],"award-info":[{"award-number":["No. BYKY-CX2023019"]}]},{"name":"Postgraduate Tutor Research Project of Bishan Hospital of Chongqing","award":["No. BYKY-DS2023007"],"award-info":[{"award-number":["No. BYKY-DS2023007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12800-2","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T15:47:21Z","timestamp":1754927241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["0.01% atropine combined with carteolol hydrochloride can inhibit the scleral remodeling in guinea pigs with form-deprivation myopia"],"prefix":"10.1038","volume":"15","author":[{"given":"Qin","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyu","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhou","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,11]]},"reference":[{"key":"12800_CR1","doi-asserted-by":"publisher","first-page":"1004977","DOI":"10.1155\/2022\/1004977","volume":"2022","author":"A Russo","year":"2022","unstructured":"Russo, A. et al. Myopia: mechanisms and strategies to slow down its progression. J. Ophthalmol. 2022, 1004977 (2022).","journal-title":"J. Ophthalmol."},{"issue":"8","key":"12800_CR2","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.4103\/ijo.IJO_2415_21","volume":"70","author":"H Singh","year":"2022","unstructured":"Singh, H. et al. Myopia, its prevalence, current therapeutic strategy and recent developments: A review. Indian J. Ophthalmol. 70 (8), 2788\u20132799 (2022).","journal-title":"Indian J. Ophthalmol."},{"issue":"4","key":"12800_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1097\/ICL.0000000000000499","volume":"44","author":"J Cooper","year":"2018","unstructured":"Cooper, J. & Tkatchenko, A. V. A review of current concepts of the etiology and treatment of myopia. Eye Contact Lens. 44 (4), 231\u2013247 (2018).","journal-title":"Eye Contact Lens"},{"issue":"1","key":"12800_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41433-018-0139-7","volume":"33","author":"PC Wu","year":"2019","unstructured":"Wu, P. C. et al. Update in myopia and treatment strategy of Atropine use in myopia control. Eye (Lond). 33 (1), 3\u201313 (2019).","journal-title":"Eye (Lond)"},{"issue":"8","key":"12800_CR5","doi-asserted-by":"publisher","first-page":"e1136","DOI":"10.1111\/aos.14166","volume":"97","author":"M Sacchi","year":"2019","unstructured":"Sacchi, M. et al. Efficacy of Atropine 0.01% for the treatment of childhood myopia in European patients. Acta Ophthalmol. 97 (8), e1136\u2013e40 (2019).","journal-title":"Acta Ophthalmol."},{"issue":"11","key":"12800_CR6","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1001\/jamaophthalmol.2020.3820","volume":"138","author":"S Wei","year":"2020","unstructured":"Wei, S. et al. Safety and efficacy of Low-Dose Atropine Eyedrops for the treatment of myopia progression in Chinese children: A randomized clinical trial. JAMA Ophthalmol. 138 (11), 1178\u20131184 (2020).","journal-title":"JAMA Ophthalmol."},{"issue":"1","key":"12800_CR7","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/j.ophtha.2018.05.029","volume":"126","author":"JC Yam","year":"2019","unstructured":"Yam, J. C. et al. Low-Concentration Atropine for myopia progression (LAMP) study: A randomized, Double-Blinded, Placebo-Controlled trial of 0.05%, 0.025%, and 0.01% Atropine eye drops in myopia control. Ophthalmology 126 (1), 113\u2013124 (2019).","journal-title":"Ophthalmology"},{"key":"12800_CR8","doi-asserted-by":"crossref","unstructured":"Ding, C. et al. EGF released from human placental mesenchymal stem cells improves premature ovarian insufficiency via NRF2\/HO-1 activation. Aging (Albany NY).\u00a012(3) (2020).","DOI":"10.18632\/aging.102794"},{"issue":"8","key":"12800_CR9","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1136\/bjo.54.8.548","volume":"54","author":"A Tomlinson","year":"1970","unstructured":"Tomlinson, A. & Phillips, C. I. Applanation tension and axial length of the eyeball. Br. J. Ophthalmol. 54 (8), 548 (1970).","journal-title":"Br. J. Ophthalmol."},{"issue":"1","key":"12800_CR10","doi-asserted-by":"publisher","first-page":"26","DOI":"10.3341\/kjo.1990.4.1.26","volume":"4","author":"DH Youn","year":"1990","unstructured":"Youn, D. H., Yu, Y. S. & Park, I. W. Intraocular pressure and axial length in children. Korean J. Ophthalmol. 4 (1), 26\u201329 (1990).","journal-title":"Korean J. Ophthalmol."},{"key":"12800_CR11","doi-asserted-by":"crossref","unstructured":"Al-Obaida, I., Owaifeer, A. M. A., Ahmad, K. & Malik, R. The relationship between axial length, age and intraocular pressure in children with primary congenital glaucoma. Sci. Rep. (2020).","DOI":"10.1038\/s41598-020-74126-5"},{"key":"12800_CR12","doi-asserted-by":"crossref","unstructured":"El-Nimri, N. W. & Wildsoet, C. F. Effects of topical Latanoprost on intraocular pressure and myopia progression in young Guinea pigs. Investig. Ophthalmol. Vis. Sci. ;59(6) (2018).","DOI":"10.1167\/iovs.17-22890"},{"issue":"S1","key":"12800_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.exer.2012.12.013","volume":"114","author":"DL Nickla","year":"2013","unstructured":"Nickla, D. L. Ocular diurnal rhythms and eye growth regulation: Where we are 50 years after Lauber. Exp. Eye Res. 114(S1), 25\u201334 (2013).","journal-title":"Exp. Eye Res."},{"issue":"2","key":"12800_CR14","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/cxo.12101","volume":"97","author":"CW Mcmonnies","year":"2014","unstructured":"Mcmonnies, C. W. An examination of the baropathic nature of axial myopia. Clin. Experimental Optometry. 97 (2), 116\u2013124 (2014).","journal-title":"Clin. Experimental Optometry"},{"issue":"1","key":"12800_CR15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/s12886-020-01610-x","volume":"20","author":"L Dong","year":"2020","unstructured":"Dong, L. et al. Lens-induced myopization and intraocular pressure in young Guinea pigs. BMC Ophthalmol. 20 (1), 343 (2020).","journal-title":"BMC Ophthalmol."},{"issue":"1","key":"12800_CR16","first-page":"1","volume":"55","author":"N Akag\u00fcn","year":"2025","unstructured":"Akag\u00fcn, N. & Alt\u0131parmak, U. E. Combination therapy with Atropine 0.05% and Myopi-X(\u00ae)glasses: is it effective in myopia control??. Turk. J. Ophthalmol. 55(1), 1\u20135 (2025).","journal-title":"Turk. J. Ophthalmol."},{"issue":"3","key":"12800_CR17","doi-asserted-by":"publisher","first-page":"510","DOI":"10.18240\/ijo.2022.03.21","volume":"15","author":"Q Yu","year":"2022","unstructured":"Yu, Q. & Zhou, J. B. Scleral remodeling in myopia development. Int. J. Ophthalmol. 15 (3), 510\u2013514 (2022).","journal-title":"Int. J. Ophthalmol."},{"key":"12800_CR18","unstructured":"Lew, M. Y., Choh, V., Wildsoet, C. F. & Nadel, M. W. Effects of interchanging hyperopic defocus and form deprivation stimuli in normal and optic nerve-sectioned chicks."},{"key":"12800_CR19","first-page":"278","volume":"19","author":"A Gentle","year":"2003","unstructured":"Gentle, A., Liu, Y., Martin, J. E., Conti, G. L. & Mcbrien, N. A. Collagen gene expression and the altered accumulation of scleral collagen during the development of high myopia. J. Biol. Chem. 19, 278 (2003).","journal-title":"J. Biol. Chem."},{"issue":"7","key":"12800_CR20","first-page":"2067","volume":"43","author":"JT Siegwart","year":"2002","unstructured":"Siegwart, J. T. & Norton, T. T. The time course of changes in mRNA levels in tree shrew sclera during induced myopia and recovery. Investig. Ophthalmol. Vis. Sci. 43 (7), 2067 (2002).","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"6","key":"12800_CR21","first-page":"1153","volume":"42","author":"JT Siegwart","year":"2001","unstructured":"Siegwart, J. T. & Norton, T. T. Steady state mRNA levels in tree shrew sclera with Form-Deprivation myopia and during recovery. Invest. Ophthalmol. Vis. 42 (6), 1153\u20131159 (2001).","journal-title":"Invest. Ophthalmol. Vis."},{"key":"12800_CR22","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.mito.2019.10.007","volume":"50","author":"A Melouane","year":"2020","unstructured":"Melouane, A., Yoshioka, M. & St-Amand, J. Extracellular matrix\/mitochondria pathway: A novel potential target for sarcopenia. Mitochondrion 50, 63\u201370 (2020).","journal-title":"Mitochondrion"},{"key":"12800_CR23","doi-asserted-by":"publisher","first-page":"108255","DOI":"10.1016\/j.exer.2020.108255","volume":"201","author":"TC Chan","year":"2020","unstructured":"Chan, T. C., Berka, J. L. W., Deliyanti, D., Hunter, D. & White, A. The role of reactive oxygen species in the pathogenesis and treatment of retinal diseases. Exp. Eye Res. 201, 108255 (2020).","journal-title":"Exp. Eye Res."},{"key":"12800_CR24","doi-asserted-by":"crossref","unstructured":"Annesley, S. J. & Fisher, P. R. Mitochondria in health and disease. Cells.\u00a08(7) (2019).","DOI":"10.3390\/cells8070680"},{"issue":"21","key":"12800_CR25","doi-asserted-by":"publisher","first-page":"R1177","DOI":"10.1016\/j.cub.2017.09.015","volume":"27","author":"AJ Roger","year":"2017","unstructured":"Roger, A. J., Munoz-Gomez, S. A. & Kamikawa, R. The origin and diversification of mitochondria. Curr. Biol. 27 (21), R1177\u2013R92 (2017).","journal-title":"Curr. Biol."},{"key":"12800_CR26","doi-asserted-by":"publisher","first-page":"8837893","DOI":"10.1155\/2020\/8837893","volume":"2020","author":"Q Jiang","year":"2020","unstructured":"Jiang, Q. et al. Mitochondria-Targeted antioxidants: A step towards disease treatment. Oxid. Med. Cell. Longev. 2020, 8837893 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"10","key":"12800_CR27","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1016\/S1063-4584(03)00150-X","volume":"11","author":"YE Henrotin","year":"2003","unstructured":"Henrotin, Y. E., Bruckner, P. & Pujol, J. P. The role of reactive oxygen species in homeostasis and degradation of cartilage. Osteoarthr. Cartil. 11 (10), 747\u2013755 (2003).","journal-title":"Osteoarthr. Cartil."},{"issue":"24","key":"12800_CR28","doi-asserted-by":"publisher","first-page":"2865","DOI":"10.1042\/CS20171246","volume":"131","author":"L Ung","year":"2017","unstructured":"Ung, L., Pattamatta, U., Carnt, N., Wilkinson-Berka Jennifer, L. & White Andrew, J. R. Oxidative stress and reactive oxygen species: a review of their role in ocular disease. Clin. Sci. 131 (24), 2865 (2017).","journal-title":"Clin. Sci."},{"key":"12800_CR29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2015\/240918","volume":"2015","author":"F Bosch-Morell","year":"2015","unstructured":"Bosch-Morell, F., M\u00e9rida, S. & Navea, A. Oxidative Stress in Myopia. Oxidative medicine and cellular longevity 2015, 1\u201312 (2015).","journal-title":"Oxidative medicine and cellular longevity"},{"key":"12800_CR30","doi-asserted-by":"publisher","first-page":"1452696","DOI":"10.1155\/2020\/1452696","volume":"2020","author":"S Rius-Perez","year":"2020","unstructured":"Rius-Perez, S., Torres-Cuevas, I., Millan, I., Ortega, A. L. & Perez, S. PGC-1alpha, inflammation, and oxidative stress: an integrative view in metabolism. Oxid. Med. Cell. Longev. 2020, 1452696 (2020).","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"6","key":"12800_CR31","doi-asserted-by":"publisher","first-page":"2870","DOI":"10.1007\/s12035-020-01924-3","volume":"57","author":"M Salman","year":"2020","unstructured":"Salman, M., Tabassum, H. & Parvez, S. Tannic acid provides neuroprotective effects against traumatic brain injury through the PGC-1alpha\/Nrf2\/HO-1 pathway. Mol. Neurobiol. 57 (6), 2870\u20132885 (2020).","journal-title":"Mol. Neurobiol."},{"key":"12800_CR32","doi-asserted-by":"publisher","first-page":"9932442","DOI":"10.1155\/2021\/9932442","volume":"2021","author":"K Siekacz","year":"2021","unstructured":"Siekacz, K., Piotrowski, W. J., Iwanski, M. A., Gorski, P. & Bialas, A. J. The role of interaction between mitochondria and the extracellular matrix in the development of idiopathic pulmonary fibrosis. Oxid. Med. Cell. Longev. 2021, 9932442 (2021).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"12800_CR33","doi-asserted-by":"publisher","first-page":"997619","DOI":"10.3389\/fphys.2022.997619","volume":"13","author":"A Mohammadi","year":"2022","unstructured":"Mohammadi, A., Higazy, R. & Gauda, E. B. PGC-1alpha activity and mitochondrial dysfunction in preterm infants. Front. Physiol. 13, 997619 (2022).","journal-title":"Front. Physiol."},{"key":"12800_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui, N., Hu, M. & Khalil, R. A. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol. Biol. Transl Sci. 147, 1\u201373 (2017).","journal-title":"Prog Mol. Biol. Transl Sci."},{"key":"12800_CR35","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1146\/annurev.cellbio.17.1.463","volume":"17","author":"MD Sternlicht","year":"2001","unstructured":"Sternlicht, M. D. & Werb, Z. How matrix metalloproteinases regulate cell behavior. Annu. Rev. Cell. Dev. Biol. 17, 463\u2013516 (2001).","journal-title":"Annu. Rev. Cell. Dev. Biol."},{"key":"12800_CR36","doi-asserted-by":"publisher","first-page":"100773","DOI":"10.1016\/j.preteyeres.2019.100773","volume":"74","author":"C Boote","year":"2020","unstructured":"Boote, C. et al. Scleral structure and biomechanics. Prog Retin Eye Res. 74, 100773 (2020).","journal-title":"Prog Retin Eye Res."},{"key":"12800_CR37","doi-asserted-by":"crossref","unstructured":"Lukomska, A. et al. Changes in gene and protein expression of Metalloproteinase-2 and \u2013\u20099 and their inhibitors TIMP2 and TIMP3 in different parts of Fluoride-Exposed rat brain. Int. J. Mol. Sci. 22(1) (2020).","DOI":"10.3390\/ijms22010391"},{"issue":"1","key":"12800_CR38","first-page":"55","volume":"32","author":"SR Yang","year":"2010","unstructured":"Yang, S. R., Ye, J. J. & Long, Q. [Expressions of collagen, matrix metalloproteases-2, and tissue inhibitor of matrix metalloproteinase-2 in the posterior sclera of newborn Guinea pigs with negative lens-defocused myopia]. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 32 (1), 55\u201359 (2010).","journal-title":"Zhongguo Yi Xue Ke Xue Yuan Xue Bao"},{"issue":"8","key":"12800_CR39","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.ajpath.2018.04.011","volume":"188","author":"F Zhao","year":"2018","unstructured":"Zhao, F. et al. Cause and effect relationship between changes in scleral matrix Metallopeptidase-2 expression and myopia development in mice. Am. J. Pathol. 188 (8), 1754\u20131767 (2018).","journal-title":"Am. J. Pathol."},{"issue":"1","key":"12800_CR40","doi-asserted-by":"publisher","first-page":"3427","DOI":"10.1038\/s41467-020-17242-0","volume":"11","author":"M Arra","year":"2020","unstructured":"Arra, M. et al. LDHA-mediated ROS generation in chondrocytes is a potential therapeutic target for osteoarthritis. Nat. Commun. 11 (1), 3427 (2020).","journal-title":"Nat. Commun."},{"key":"12800_CR41","doi-asserted-by":"crossref","unstructured":"Miwa, S., Kashyap, S., Chini, E. & von Zglinicki, T. Mitochondrial dysfunction in cell senescence and aging. J. Clin. Invest. (2022).","DOI":"10.1172\/JCI158447"},{"issue":"6","key":"12800_CR42","doi-asserted-by":"publisher","first-page":"114","DOI":"10.15698\/cst2020.06.221","volume":"4","author":"D Grasso","year":"2020","unstructured":"Grasso, D., Zampieri, L. X., Capeloa, T., Van de Velde, J. A. & Sonveaux, P. Mitochondria in cancer. Cell. Stress. 4 (6), 114\u2013146 (2020).","journal-title":"Cell. Stress"},{"issue":"24","key":"12800_CR43","doi-asserted-by":"publisher","first-page":"e105074","DOI":"10.15252\/embj.2020105074","volume":"39","author":"D Murata","year":"2020","unstructured":"Murata, D. et al. Mitochondrial safeguard: a stress response that offsets extreme fusion and protects respiratory function via flickering-induced Oma1 activation. EMBO J. 39 (24), e105074 (2020).","journal-title":"EMBO J."},{"key":"12800_CR44","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.ejphar.2017.07.041","volume":"815","author":"S Li","year":"2017","unstructured":"Li, S. et al. Baicalin attenuates in vivo and in vitro hyperglycemia-exacerbated ischemia\/reperfusion injury by regulating mitochondrial function in a manner dependent on AMPK. Eur. J. Pharmacol. 815, 118\u2013126 (2017).","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"12800_CR45","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1139\/apnm-2020-0005","volume":"45","author":"JF Halling","year":"2020","unstructured":"Halling, J. F. & Pilegaard, H. PGC-1alpha-mediated regulation of mitochondrial function and physiological implications. Appl. Physiol. Nutr. Metab. 45 (9), 927\u2013936 (2020).","journal-title":"Appl. Physiol. Nutr. Metab."},{"key":"12800_CR46","doi-asserted-by":"publisher","first-page":"108380","DOI":"10.1016\/j.neuropharm.2020.108380","volume":"182","author":"J Wen","year":"2021","unstructured":"Wen, J. et al. Tetramethylpyrazine nitrone improves motor dysfunction and pathological manifestations by activating the PGC-1alpha\/Nrf2\/HO-1 pathway in ALS mice. Neuropharmacology 182, 108380 (2021).","journal-title":"Neuropharmacology"},{"issue":"9","key":"12800_CR47","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1248\/bpb.b17-00313","volume":"40","author":"X Zhang","year":"2017","unstructured":"Zhang, X. et al. A novel Danshensu-Tetramethylpyrazine conjugate DT-010 provides cardioprotection through the PGC-1alpha\/Nrf2\/HO-1 pathway. Biol. Pharm. Bull. 40 (9), 1490\u20131498 (2017).","journal-title":"Biol. Pharm. Bull."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12800-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12800-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T23:09:26Z","timestamp":1757372966000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12800-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,11]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12800"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12800-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,11]]},"assertion":[{"value":"3 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29392"}}